Skip to main content

Mental Health

Volume 450: debated on Tuesday 24 October 2006

To ask the Secretary of State for Health (1) What assessment she has made of the impact the proposed withdrawal of Ebixa will have on the treatment of people in the later stages of Alzheimer's with particular reference to behavioural symptoms. (91993)

(2) What assessment she has made of the impact of the recommendations of the National Institute for Health and Clinical Excellence on the prescription of Alzheimer’s drugs on (a) people with dementia, (b) carers of people with dementia and (c) families of people with dementia.

I refer my hon. Friend to the replies I gave on 13 July 2006, Official Report, column 2035-36W.